GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » Price-to-Owner-Earnings

Binex Co (XKRX:053030) Price-to-Owner-Earnings : (As of May. 31, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Binex Co Price-to-Owner-Earnings?

As of today (2025-05-31), Binex Co's share price is ₩17530.00. Binex Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Binex Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Binex Co was 1505.71. The lowest was 12.97. And the median was 62.62.


XKRX:053030's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.765
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-31), Binex Co's share price is ₩17530.00. Binex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-809.60. Therefore, Binex Co's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-31), Binex Co's share price is ₩17530.00. Binex Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-664.93. Therefore, Binex Co's PE Ratio without NRI for today is At Loss.

During the past 13 years, Binex Co's highest PE Ratio without NRI was 178.82. The lowest was 0.00. And the median was 46.99.


Binex Co Price-to-Owner-Earnings Historical Data

The historical data trend for Binex Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binex Co Price-to-Owner-Earnings Chart

Binex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 260.53 15.22 271.32 - -

Binex Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Binex Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, Binex Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binex Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Binex Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Binex Co's Price-to-Owner-Earnings falls into.


;
;

Binex Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Binex Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=17530.00/-1399.41
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Binex Co  (XKRX:053030) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Binex Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Binex Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Binex Co Business Description

Traded in Other Exchanges
N/A
Address
480-2 Janglim-dong, Saha-gu, Busan, KOR, 604-846
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.

Binex Co Headlines

No Headlines